This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print this page

Social Networks for Life Sciences

Valuable communication tool or just tweets and word games

Start date and time

December 14, 2010 12:00 PM

End date and time

December 14, 2010 1:00 PM

Time zone:

(GMT-05:00) Eastern Time (US & Canada)

Registration options

Online

Event registration is closed.

Log-in on Tuesday, December 14, 2010, 12:00 pm ET to hear about Deloitte's new study, To friend or not? New insights about social networks in the life sciences industry.  Gain a better understanding of the value of social networks and begin to think about how the effective use of social networks can help jump start innovation, reduce costs and improve efficiency across your organization.

Why attend:

Leaders in strategy, innovation, marketing and communications need to understand how to leverage the value of external social networks while at the same time avoiding risk.  Discovering the true value of social networks requires a thorough understanding of its dynamics and the applications being powered. This webinar includes original research that will help companies understand what works and what doesn't.

Deloitte's  research on the use of social networks in life sciences was compiled through interviews of industry and health 2.0 leaders.  At the same time, Sermo, a physicians' network, conducted research to understand how their member doctors view industry participation in social networks.

Panel:

  1. Terry Hisey, Vice Chairman and U.S. Life Sciences Leader, Deloitte Services LP
  2. Chris Franck, Principal, Deloitte Consulting LLP
  3. Daniel Palestrant, President, Sermo BIO

They will address key questions, including:

  • How are social networks adding value to life sciences companies: now and in the future?
  • Do companies need their own social networks to gain value?
  • When is it useful to use Facebook, Twitter or a special health care community?
  • How is the industry currently using social networks and what do they plan to do?
  • How do physicians view the engagement with life sciences companies on social networks?

There is no cost to participate In this webcast.

To learn more about Life Sciences at Deloitte, visit us at www.deloitte.com/us/lifesciences.

Event registration is closed.

Related links